As one of 67 institutes of the Fraunhofer-Gesellschaft, Fraunhofer IGB is part of Europe’s largest organizsation for applied research. Dedicated scientists can utilize their full potential, starting with application-oriented fundamental research up to the realizing innovative products and applications. Our scientists work on a wide range of research projects that offer a high degree of responsibility and individual design scope. Fraunhofer IGB is committed to excellence in its research activities and maintains close ties with institutions engaged in fundamental research. Networking focuses on national as well as international Universities and Colleges.
Our overriding goal is the translation of scientific and engineering research results into similarly economically efficient and sustainable processes and products. More than ever, the success of new products and processes is dependent on interdisciplinary and constructive cooperation between science and engineering. Experts in the fields of chemistry, physics, biology, and engineering work effectively together at Fraunhofer IGB, its branches at Leuna, Straubing and Würzburg, and our Stuttgart University IGVP partner institute. Customers benefit from the synergies and multidisciplinary potential at our institute, which facilitate novel approaches and innovative solutions in areas such as medical engineering, nanotechnology, industrial biotechnology, and environmental technology.
The "Fraunhofer Attract" grant is the excellence stipend program which invites outstanding researchers to develop their ideas towards innovations at Fraunhofer. Funded by this program Prof. Dr. Katja Schenke-Layland came back from the USA to lead the "Cardiovascular Tissue Engineering" Attract group before becoming head of the "Cell and Tissue Engineering" Department and, later on, Director of Fraunhofer IGB. In 2016, Fraunhofer IGB once more profited from the program with Dr. Peter Loskill coming from Berkeley to manage the Organ-on-a-Chip Attract Group.